...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Free
Message: Roth Conference March 19th 11:00 AM Fireside Chat

Today is day 35 since we last got news, and 5 days past when we were told that further financing news was "anticipated".  

On top of that we've been stuck in a range of about $3.00 to $3.40 from late September til now....at times a little below or above that range for very brief periods, but for the most part I think that range is pretty reliable.  

Can someone go to the following link and open up the Excel spreadsheet to see what the Short # was on Feb 28th?

http://www.iiroc.ca/industry/marketmonitoringanalysis/Pages/consolidated-short-position-report.aspx

Just click on the link for:  

3/6/2019

20190228_CSPR_Report

 

Then just scroll down (or CTRL F search) for Resverlogix.

Share
New Message
Please login to post a reply